Denali Growth Partners

Denali Growth Partners is a Boston-based growth equity firm specializing in healthcare and technology investments. The firm partners with exceptional entrepreneurs to support the growth of capital-efficient and profitable companies. As of May 1, 2025, Denali manages over $750 million in Regulatory Assets Under Management.

The firm's investment strategy focuses on sectors where its domain expertise aligns with real-world business performance, including healthcare, life sciences, professional services, technology-enabled platforms and services, and software. Denali seeks to invest in companies that are lowering the cost of care while improving health outcomes and enhancing the delivery and consumption of healthcare services.

Denali's team comprises passionate investors and operators committed to supporting portfolio companies in their next stage of growth. The firm offers operational support by introducing resources, relationships, and best practices to help companies scale effectively. Additionally, Denali has an executive network of over 30 healthcare and technology executives who provide guidance and support to the entrepreneurs the firm backs.

Denali Growth Partners has a track record of successful investments, including a $400 million raise for its second growth equity fund in May 2025, which exceeded its $350 million target. The firm has invested in 11 platform companies that collectively generate over $900 million in revenue, produce more than $100 million in EBITDA, and employ over 3,000 individuals.

Denali Growth Partners is headquartered at 545 Boylston Street, Suite 1101, Boston, MA 02116. For more information, visit their official website at https://www.denaligrowth.com/ or contact them via email at info@denaligrowth.com.

Denali Growth Partners is a Boston-based growth equity firm specializing in healthcare and technology investments. The firm partners with exceptional entrepreneurs to support the growth of capital-efficient and profitable companies. As of May 1, 2025, Denali manages over $750 million in Regulatory Assets Under Management.

The firm's investment strategy focuses on sectors where its domain expertise aligns with real-world business performance, including healthcare, life sciences, professional services, technology-enabled platforms and services, and software. Denali seeks to invest in companies that are lowering the cost of care while improving health outcomes and enhancing the delivery and consumption of healthcare services.

Denali's team comprises passionate investors and operators committed to supporting portfolio companies in their next stage of growth. The firm offers operational support by introducing resources, relationships, and best practices to help companies scale effectively. Additionally, Denali has an executive network of over 30 healthcare and technology executives who provide guidance and support to the entrepreneurs the firm backs.

Denali Growth Partners has a track record of successful investments, including a $400 million raise for its second growth equity fund in May 2025, which exceeded its $350 million target. The firm has invested in 11 platform companies that collectively generate over $900 million in revenue, produce more than $100 million in EBITDA, and employ over 3,000 individuals.

Denali Growth Partners is headquartered at 545 Boylston Street, Suite 1101, Boston, MA 02116. For more information, visit their official website at https://www.denaligrowth.com/ or contact them via email at info@denaligrowth.com.